Skip directly to site content Skip directly to search


Español  Other Languages


Centers for Disease Control and Prevention. CDC twenty four seven. Saving Lives, Protecting People
 Search
		×
			NIOSH
			NIOSH
				All CDC
				Submit
			For a full list of topics:A-Z Index
			Advanced Search
		Advanced Search


The National Institute for Occupational Safety and Health (NIOSH)








ATRAZINE										Related Pages
										*OSHA comments from the January 19, 1989 Final Rule on Air Contaminants Project extracted from 54FR2332 et. seq. This rule was remanded by the U.S. Circuit Court of Appeals and the limits are not currently in force.*
**CAS:** 1912-24-9; **Chemical Formula:** C8H14ClN5
Formerly, OSHA had no limit for atrazine; an 8-hour TWA of 5mg/m3 was proposed. The final rule establishes this limit, which is consistent with that of the ACGIH. NIOSH (Ex. 8-47, Table N1) concurs with this limit for atrazine. Atrazine is a stable, white, crystalline compound.
Animal studies indicate that the oral toxicity of thes-triazine herbicides, of which atrazine is the best known, is relatively low. However, the ingestion of high doses can cause ataxia, dyspnea and convulsions in animals (ACGIH 1986/Ex. 1-3, p. 44). Rats, dogs, horses, or cattle fed dietary levels of more than 25 ppm of atrazine for extended periods did not exhibit adverse effects. The s-triazine herbicides are apparently excreted in urine and feces within relatively short periods of time (Bakke, Larson, and Price 1972/Ex. 1-950). The s-triazines appear to interfere with carbohydrate metabolism by blocking the production of sugars (Gysin 1962/Ex. 1-740; Gast 1958, as cited in ACGIH 1986/Ex.1-3, p. 44).
There have not been reports of atrazine poisoning in exposed people (ACGIH 1986/Ex. 1-3, p. 44). Because there are no reports of human reactions to atrazine that can be correlated with airborne concentrations, the 5 mg/m3 limit was set on the basis of animal studies. Long-term feeding studies in dogs have established 3.75 mg/kg as the highest no-adverse-effect level (PEA 1979, as cited in ACGIH 1986/Ex. 1-3,p. 44).Assuming that lung absorption is less than 50 percent and applying a safety factor would yield an 8-hour TWA limit for humans of 5mg/m3 (Zielhuis and van der Kreek 1979/Ex. 1-613).
Wayne Bellinger, Corporate Safety Director of ConAgra, Inc. objected to the establishment of permissible exposure limits on the basis of a no-adverse-effect level (Ex. 3-635). In support of this position, ConAgra referred to the proposed limit for atrazine; according to ConAgra, PELs should not be set “where there are no reports of human reactions that can be attributed to air concentrations” (Ex. 3-635, p. 2).
OSHA believes that ConAgra has misunderstood the phrase “no-observed-adverse-effect level” as it is used in toxicology. As discussed in the Description of the Health Effects section, above, this term simply means a level below which overt toxic effects have not been observed and above which they have. The use of a no-observed-adverse-effect level to establish “acceptable” exposure levels, intake values, etc. is common, both in the health effects literature and in public health agencies; this approach is widely used with substances that have threshold effects. In addition, it is standard toxicological practice to rely on animal data when human data are sparse or nonexistent, as is the case for atrazine. OSHA has reviewed the health effects evidence for this substance and finds the proposed rule’s limit both appropriate and necessary to protect against significant workplace risk.
In the final rule, OSHA is establishing an 8-hour TWA PEL of5 mg/m3 for atrazine. The Agency concludes that this limit will protect employees from the significant risk of neuropathic and metabolic effects, which constitute material health impairments that are likely to occur at levels above the new PEL.
							
					
							Last Reviewed:  September 28, 2011						Source: 	National Institute for Occupational Safety and Health
					Facebook
        Twitter
        LinkedIn
        Syndicate NIOSH
1988 OSHA PEL Project Documentation
Index of Chemical Names
Index of CAS Numbers Follow NIOSH Facebook
Pinterest
Twitter
YouTube
 NIOSH Homepage NIOSH A-Z
Workplace Safety & Health Topics
Publications and Products
Programs
Contact NIOSH


About CDC
					Contact Us
					800-232-4636
 Facebook Twitter Instagram LinkedIn Youtube Pinterest Snapchat
 CONTACT CDC
				Contact Us
							Call 800-232-4636
							Email Us
			ABOUT CDC
				About CDC
							Jobs
							Funding
			POLICIES
				Accessibility
							External Links
							Privacy
							Policies
							No Fear Act
							FOIA
							OIG
							Nondiscrimination
							Vulnerability Disclosure Policy
			CONNECT WITH US
				Facebook
								Twitter
								Instagram
								LinkedIn
							Youtube
								Pinterest
								Snapchat
								Email
			LANGUAGES
				Español
							繁體中文
							Tiếng Việt
							한국어
							Tagalog
							Русский
							العربية
							Kreyòl Ayisyen
							Français
							Polski
							Português
							Italiano
							Deutsch
							日本語
							فارسی
							English


U.S. Department of Health & Human Services
			Accessibility
			External Links
			Privacy
			Policies
			No Fear Act
			FOIA
			Nondiscrimination
			OIG
			Vulnerability Disclosure Policy
			USA.gov


Exit Notification / Disclaimer Policy Close
 Links with this icon  indicate that you are leaving the CDC website. The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
				Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
				You will be subject to the destination website's privacy policy when you follow the link.
				CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website. Website Disclaimers
 Cancel Continue